WO2009128089A3 - Novel solvate form of sumatriptan succinate and process for preparing sumatriptan salt employing the same - Google Patents

Novel solvate form of sumatriptan succinate and process for preparing sumatriptan salt employing the same Download PDF

Info

Publication number
WO2009128089A3
WO2009128089A3 PCT/IN2009/000089 IN2009000089W WO2009128089A3 WO 2009128089 A3 WO2009128089 A3 WO 2009128089A3 IN 2009000089 W IN2009000089 W IN 2009000089W WO 2009128089 A3 WO2009128089 A3 WO 2009128089A3
Authority
WO
WIPO (PCT)
Prior art keywords
sumatriptan
solvate
same
preparing
solvate form
Prior art date
Application number
PCT/IN2009/000089
Other languages
French (fr)
Other versions
WO2009128089A2 (en
Inventor
Debashish Datta
Saswata Lahiri
Purandhar Koilkonda
Jitendra Sharma
Mouneshwar Achar
Venkata Naga Vikas Chandra Ravi
Original Assignee
Matrix Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Laboratories Limited filed Critical Matrix Laboratories Limited
Publication of WO2009128089A2 publication Critical patent/WO2009128089A2/en
Publication of WO2009128089A3 publication Critical patent/WO2009128089A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a novel solvate of sumatriptan succinate, wherein the solvate is an ethanol solvate and is characterized by using different solid state techniques such as powder X-ray diffraction, differential scanning calorimetry and thermo gravimetric analysis. In addition, the present invention discloses a process for the preparation of said solvate, and pure and improved quality of sumatriptan succinate employing said solvate.
PCT/IN2009/000089 2008-02-11 2009-02-09 Novel solvate form of sumatriptan succinate and process for preparing sumatriptan salt employing the same WO2009128089A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN346CH2008 2008-02-11
IN346/CHE/2008 2008-02-11

Publications (2)

Publication Number Publication Date
WO2009128089A2 WO2009128089A2 (en) 2009-10-22
WO2009128089A3 true WO2009128089A3 (en) 2010-03-11

Family

ID=41199537

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000089 WO2009128089A2 (en) 2008-02-11 2009-02-09 Novel solvate form of sumatriptan succinate and process for preparing sumatriptan salt employing the same

Country Status (1)

Country Link
WO (1) WO2009128089A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037845A (en) * 1984-08-01 1991-08-06 Glaxo Group Limited Indole derivative
WO2004076403A1 (en) * 2003-02-24 2004-09-10 Transform Pharmaceuticals, Inc. Sumatriptan crystalline forms, pharmaceutical compositions and methods
WO2004099140A1 (en) * 2003-05-08 2004-11-18 Hetero Drugs Limited Novel crystalline forms of sumatriptan succinate
US20060106227A1 (en) * 2002-06-13 2006-05-18 Dr Reddy's Laboratories Limited 3-'2-(Dimethylamino) ethyl!-n-methyl-1h-indole-5-methanesulfonamide and the succinate thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037845A (en) * 1984-08-01 1991-08-06 Glaxo Group Limited Indole derivative
US20060106227A1 (en) * 2002-06-13 2006-05-18 Dr Reddy's Laboratories Limited 3-'2-(Dimethylamino) ethyl!-n-methyl-1h-indole-5-methanesulfonamide and the succinate thereof
WO2004076403A1 (en) * 2003-02-24 2004-09-10 Transform Pharmaceuticals, Inc. Sumatriptan crystalline forms, pharmaceutical compositions and methods
WO2004099140A1 (en) * 2003-05-08 2004-11-18 Hetero Drugs Limited Novel crystalline forms of sumatriptan succinate

Also Published As

Publication number Publication date
WO2009128089A2 (en) 2009-10-22

Similar Documents

Publication Publication Date Title
NZ592504A (en) Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
UA97478C2 (en) Crystalline form vi of agomelatine, a process for its preparation and pharmaceutical compositions containing it
WO2007067566A3 (en) Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
WO2009053854A3 (en) Polymorphs of dasatinib and process for preparation thereof
NZ629684A (en) Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
ME02689B (en) New crystalline form iii of agometalin, the process for its preparation and pharmaceutical compositions containing it
WO2012097333A3 (en) Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
WO2010091877A3 (en) Process for producing ambrisentan
WO2007141593A3 (en) Process for the preparation of metoprolol and its salts
JP2008019161A5 (en)
WO2012138907A3 (en) Solid forms of curcumin
EP1837617A3 (en) Process for manufacture of a latent heat storage body
WO2013120940A3 (en) Nematicidal cis (hetero)arylcyclopropylcarboxamide derivatives
WO2008151828A3 (en) Novel microbiocides
WO2012075117A3 (en) Small molecule-polymer conjugates and methods of making same
WO2008133962A3 (en) Thermal insulative product and related methods
WO2009007115A8 (en) Tropane derivatives useful as pesticides
WO2011024192A3 (en) Novel polymorphs of raltegravir
UA105767C2 (en) Amorphous prothioconazole, microbicidal composition based thereon, process for the preparation thereof
WO2013042135A8 (en) Heteroaryl compounds as 5-ht4 receptor ligands
WO2010140139A3 (en) Crystalline forms of 6-(1h- imadazol- 1-yl) -2-phenylquinazoline
WO2010027848A3 (en) Forms of lapatinib compounds and processes for the preparation thereof
WO2009128089A3 (en) Novel solvate form of sumatriptan succinate and process for preparing sumatriptan salt employing the same
MY158907A (en) Metabolites in animal feed
NZ742695A (en) Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09732054

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09732054

Country of ref document: EP

Kind code of ref document: A2